Efficacy of somatostatin analogues versus other systemic therapies as first-line palliative treatment for patients with advanced, grade 2, well-differentiated neuroendocrine tumours of extra-pulmonary origin with a Ki-67 index between 10% and 20%
Eleni Vrana, Klaire Exarchou, Amina Dawoodji, Cong Zhou et autres
0 citationsEndocrine Abstracts